
eBook - ePub
Biomarkers in Cancer Detection and Monitoring of Therapeutics
Volume 1: Discovery and Technologies
- 400 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
eBook - ePub
Biomarkers in Cancer Detection and Monitoring of Therapeutics
Volume 1: Discovery and Technologies
About this book
Molecular Biomarkers in Cancer Detection and Monitoring of Therapeutics, Volume One, Discovery and Technologies discusses how molecular biomarkers are used to determine predisposition, facilitate detection, improve treatment and offer prevention guidelines for different cancer types. This first volume in the series focuses on techniques and approaches recently developed to assist in the decision of which biomarker to use for specific conditions. Topics covered include circulating tumor cells and circulating tumor DNA, exomes, tumor microenvironment, gene editing, artificial intelligence and robotics. In addition, the book discusses the development and applications of organoids and precision medicine.This book will be a valuable resource for cancer researchers, oncologists, graduate students and members of the biomedical field who are interested in the potential of biomarkers in cancer research.
- Provides up-to-date information on current molecular biomarkers research for cancer
- Presents basic research aspects and novel technologies applied in the discovery of new biomarkers
- Discusses several technologies, including artificial intelligence, robotics, data mining, gene editing, omics and their applicability for specific cancer types
Frequently asked questions
Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Biomarkers in Cancer Detection and Monitoring of Therapeutics by Ranbir Chander Sobti,Awtar Krishan,Aastha Sobti in PDF and/or ePUB format, as well as other popular books in Business & Business Intelligence. We have over one million books available in our catalogue for you to explore.
Information
Table of contents
- Title of Book
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Preface
- Chapter One Milestones in cancer research
- Chapter Two Cancer burden: Epidemiology, racial, and geographical disparities
- Chapter Three Technological evolution in cancer diagnosis and therapeutics
- Chapter Four How does time speak about cancer, its diagnosis, treatments, and challenges?
- Chapter Five Role of artificial intelligence in cancer diagnostics and therapeutics
- Chapter Six Addressing the diagnosis and therapeutics of malignant tumor cells
- Chapter Seven Insights into genetic predisposition of somatic cancers
- Chapter Eight The use of tumor markers in prognosis of cancer and strategies to prevent cancer predisposition and progress
- Chapter Nine Cytogenetics to multiomics in biology of cancer
- Chapter Ten Role of noncoding RNA as biomarkers for cancer
- Chapter Eleven Viral miRNAs role as diagnostic, prognostic biomarkers for cancer and infectious diseases
- Chapter Twelve Pharmacogenomics and oncology: A therapeutic approach for cancer treatment
- Chapter Thirteen Obesity: Emerging risk factor for cancer beyond metabolic syndrome
- Chapter Fourteen Homologous repair deficiency and PARP inhibitors in cancer management
- Chapter Fifteen Molecular prospects of transcription activator-like effector nucleases (TALENs) in cancer management: Challenges and adaptations
- Chapter Sixteen Immunopeptidomic approaches for management of cancer
- Chapter Seventeen Regulation of tumor microenvironment by nutrient trafficking
- Chapter Eighteen Environmental factors influencing epigenetic changes initiating neoplastic changes
- Chapter Nineteen Somatic mutation: Pharmacogenomics in oncology care
- Chapter Twenty Precision medicine: Dose for anticancer therapy
- Index